Follow-up Of Intraductal Papillary Mucinous Neoplasm Research Articles

Intraduktale papillär-muzinöse Neoplasien (IPMN) des Pankreas – Standards und neue Aspekte

Intraductal papillary mucinous neoplasms (IPMN) of the pancreas belong to the heterogeneous group of cystic pancreatic lesions and have been diagnosed more frequently in recent years. Diagnosis and differentiation from other cystic lesions (pseudocysts, serous-cystic neoplasias [SCN], mucinous-cystic neoplasias [MCN], intraductal papillary-mucinous neoplasias [IPMN] and solid pseudopapillary neoplasias [SPN]) is often challenging. IPMN of the pancreas are considered as precursor lesions for the development of invasive pancreatic cancer. However, depending on the morphological (MD-IPMN, BD-IPMN) and histological subtype (intestinal, pancreatobiliary, oncocytic or gastric) the malignant potential of IPMNs varies significantly. Hence, early diagnosis and selection of the appropriate therapeutic strategy is necessary for optimal outcome and cure. There is a strong consensus for the resection of all MD-IPMN. Small BD-IPMN without signs of malignancy can be followed by observation. The increasing understanding of the histopathology and tumour biology of IPMN has led to an amendment of the 2006 International Association of Pancreatology (IAP) guidelines for the treatment of cystic pancreatic tumours. In consideration of recent data, recommendations for observation and/or follow-up of IPMN cannot be given definitely.

Sa1515 Detection of Small Concomitant Carcinomas Distinct From Intraductal Papillary Mucinous Neoplasms Under Surveillance of the Whole Pancreas Using EUS

During follow-up of intraductal papillary mucinous neoplasms (IPMNs), concomitant pancreatic carcinomas sometimes occur. The role of EUS was evaluated on follow-up of IPMNs and early detection of PDACs. Patients and

Mo1381 Role of EUS in Detection and Follow-Up of Intraductal Papillary Mucinous Neoplasms and Concomitant Invasive Carcinomas

Recently, intraductal papillary mucinous neoplasms (IPMN) have been recognized to be accompanied with ordinary pancreatic ductal adenocarcinomas (PDAC). Among several imaging examinations, endoscopic ultrasonography (EUS) is superior to any other modality with respect to spatial resolution. We employed EUS for diagnosis as well as follow-up of IPMNs, and evaluated its role in characterization of mural nodules and detection of PDAC.

Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas

Background:Synchronous occurrence of intraductal papillary mucinous neoplasm (IPMN) and ductal carcinoma of the pancreas has been reported. Branch duct IPMNs with lower likelihood of malignancy are not submitted to resection...